VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹16 Cr | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-0.68 Cr |
| Mar2021 | ₹3.63 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 42.73 | |
| Mar2024 | ₹11 Cr | 2.54 | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-0.68 Cr | Negative | |
| Mar2021 | ₹3.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹974.0 Cr | -4.3% | -7.6% | 133.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.3% |
-7.6% |
133.5% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses